| Autor: |
Li XJ; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Hou C; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Qiu W; Department of Neurology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China., Chen LF; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Zeng YR; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Zhu HX; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Tian Y; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Peng BW; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Wu WL; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Gan YY; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Liang HC; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China., Chen WX; Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China. |
| Abstrakt: |
Objective: To analyze the clinical features, outcome and prognosis of pediatric myelin oligodendrocyte glycoprotein (MOG) antibody associated acute disseminated encephalomyelitis (ADEM), and provide evidence for improving the diagnosis and treatment of this disease. Methods: This study involved 30 MOG antibody-associated ADEM patients in the Department of Neurology, Guangzhou Women and Children's Medical Center. Patients' clinical information were analyzed. Results: The mean onset age was (5.2±3.3) years old, the ration of male to female was 16∶14. Fifty percent of these patients had a history of precede infection or vaccination before onset. Encephalopathy and seizures were the most common clinical manifestations, followed by movement disorder. In addition, some patients had other positive autoantibodies. Brain Magnetic resonance imaging (MRI) showed extensive, asymmetrical, indefinite large patchy lesions in bilateral cortical and subcortical areas and the spinal cord was characterized by long segmental myelitis. In acute attack, the patients had a good response to corticosteroid combined immunoglobulin therapy. Most of these patients had a good prognosis and recurrence rate was about 20%. Conclusions: The onset age of MOG antibody-associated ADEM is around 5 years old. Encephalopathy and seizures were the most common clinical manifestations. Most patients have a good response to corticosteroid combined immunoglobulin therapy. Some patients may have a recurrent disease course. |
